O
GBT
OrbiMed’s Global Blood Therapeutics, Inc. GBT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-2,044,000
| Closed | -$65.3K | – | 149 |
|
|
2022
Q2 | $65.3K | Buy |
2,044,000
+467,400
| +30% | +$14.9K | 1.18% | 28 |
|
|
2022
Q1 | $54.6M | Buy |
+1,576,600
| New | +$54.6M | 0.89% | 35 |
|
|
2018
Q4 | – | Sell |
-309,500
| Closed | -$11.8M | – | 148 |
|
|
2018
Q3 | $11.8M | Sell |
309,500
-137,775
| -31% | -$5.24M | 0.14% | 106 |
|
|
2018
Q2 | $20.2M | Sell |
447,275
-1,019,255
| -70% | -$46.1M | 0.24% | 90 |
|
|
2018
Q1 | $70.8M | Sell |
1,466,530
-691,200
| -32% | -$33.4M | 0.88% | 39 |
|
|
2017
Q4 | $84.9M | Sell |
2,157,730
-235,905
| -10% | -$9.28M | 1.07% | 27 |
|
|
2017
Q3 | $74.3M | Buy |
2,393,635
+221,700
| +10% | +$6.88M | 0.71% | 42 |
|
|
2017
Q2 | $59.4M | Buy |
2,171,935
+1,087,435
| +100% | +$29.7M | 0.62% | 50 |
|
|
2017
Q1 | $40M | Buy |
+1,084,500
| New | +$40M | 0.45% | 58 |
|